Sabby Management, LLC Seelos Therapeutics, Inc. Transaction History

Sabby Management, LLC

  • $1.52 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.16 - $1.64 $1.89 Million - $19.3 Million
11,792,861 New
11,792,861 $2.12 Million
Q2 2020

Aug 14, 2020
SELL
$0.42 - $1.51 $213,360 - $767,080
-508,000 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$0.47 - $1.56 $238,760 - $792,480
508,000 New
508,000 $249,000
Q4 2019

Feb 14, 2020
SELL
$0.72 - $1.52 $353,690 - $746,680
-491,237 Closed
0 $0
Q3 2019

Nov 15, 2019
BUY
$0.92 - $2.15 $451,938 - $1.06 Million
491,237 New
491,237 $451,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0
View Full List

About SEELOS THERAPEUTICS, INC.

SEEL Quotes by TradingView
  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $312M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email